コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (15 surgical, 2 transthoracic needle, and 1 bronchoscopic).
3 factors and their "cellular localization" in bronchoscopic airway biopsies from patients with COPD, a
4 made conditional recommendations to perform bronchoscopic airway survey, bronchoalveolar lavage, eso
10 tyrosine] before, immediately and 48 h after bronchoscopic antigen (Ag) challenge of the peripheral a
11 achieved in animals without surgery using a bronchoscopic approach and a novel fibrin-based glue sys
12 ith emphysema, and has generated interest in bronchoscopic approaches that might achieve the same eff
13 ts at the time of transplantation and during bronchoscopic assessments for acute cellular rejection.
17 nalyzed pulmonary function tests, blood, and bronchoscopic biopsies from 21 healthy control subjects
18 ational bronchoscopy for patients undergoing bronchoscopic biopsy of a peripheral pulmonary lesion.
19 ies subsequent to a previous percutaneous or bronchoscopic biopsy or previous surgical biopsy or rese
20 dosonographic nodal aspiration compared with bronchoscopic biopsy resulted in greater diagnostic yiel
21 hology, in most cases of samples obtained by bronchoscopic biopsy, should be undertaken by pathologis
23 ar lavage is often used as an alternative to bronchoscopic bronchoalveolar lavage in the diagnosis of
25 ons occurred in only two patients (4% of the bronchoscopic broncholithectomy group), both with partia
26 nologies to assess basal cells isolated from bronchoscopic brushings of nonsmokers, smokers, and smok
27 Mechanical ventilation, fluids, pressors, bronchoscopic cast removal, daily lung computed tomograp
29 ) was predominantly lymphocytic (49.2%), and bronchoscopic cryobiopsy showed fibrotic interstitial pr
30 ecipients with pulmonary fibrosis and on one bronchoscopic cryobiospy sample from a patient with idio
31 chiectasis and history of positive sputum or bronchoscopic culture for target Gram-negative organisms
33 phase I dose-escalation pilot trial assessed bronchoscopic delivery of AdV-tk in patients with suspec
35 cation rates of electromagnetic navigational bronchoscopic (ENB)-guided and computed tomography (CT)-
36 nfirmed absence of collateral ventilation to bronchoscopic endobronchial-valve treatment (EBV group)
37 : In SARP (n = 128), AR gene expression from bronchoscopic epithelial brushings was positively associ
38 can often be useful, but invasive testing by bronchoscopic evaluation or acquisition of tissue by one
39 epithelial barrier (AEB)-on-a-chip and human bronchoscopic ex vivo airway tissue models, comparativel
42 ermediate-risk patients with a nondiagnostic bronchoscopic examination, a negative classifier score p
46 tify subphenotypes of asthma by using blood, bronchoscopic, exhaled nitric oxide, and clinical data f
48 nchial brushings from 40 participants in the Bronchoscopic Exploratory Research Study of Biomarkers i
52 Lymphocyte growth assay was performed on bronchoscopic fragments of tissue cultured in medium wit
53 mans with and without chronic cough.Methods: Bronchoscopic human airway biopsies were immunolabeled f
55 approach that utilizes presensitization and bronchoscopic inoculation to reliably produce cavities i
59 ng volume reduction using nitinol coils is a bronchoscopic intervention inducing regional parenchymal
60 he PPCs compromised of atelectasis requiring bronchoscopic intervention, pneumonia, and acute lung in
62 ation with a novel technique combining awake bronchoscopic intubation supported with nasally delivere
64 Nonbronchoscopic lavage is not comparable to bronchoscopic lavage and as such cannot be used as an al
65 as such cannot be used as an alternative to bronchoscopic lavage for assessing alveolar inflammation
66 ic lavage could be used as an alternative to bronchoscopic lavage for the assessment of alveolar perm
69 spite reports to the contrary, we have found bronchoscopic lung biopsy to be a safe and effective dia
71 ative, less-invasive biopsy methods, such as bronchoscopic lung cryobiopsy (BLC), are highly desirabl
72 Lung volume reduction surgery (LVRS) and bronchoscopic lung volume reduction (bLVR) are palliativ
79 laced to achieve unilateral lobar occlusion (bronchoscopic lung volume reduction) or a bronchoscopy w
84 well as definitive management with advanced bronchoscopic placement of valves or occlusion devices.
91 ger species complex, was most prevalent from bronchoscopic protected brush samples and significantly
92 ionale: Targeted lung denervation (TLD) is a bronchoscopic radiofrequency ablation therapy for chroni
99 CT scans were obtained 1 week or less before bronchoscopic sampling or biopsy in 48 pediatric patient
100 d detect hypoventilation during induction of bronchoscopic sedation and starting bronchoscopy followi
101 cells recruited into the human airway after bronchoscopic segmental allergen challenge of asthmatic
102 subjects with mild allergic asthma underwent bronchoscopic segmental bronchoprovocation with allergen
103 ellows demonstrated that after performing 20 bronchoscopic simulations, the skill level acquired with
105 edictive value of this test, PCR analysis of bronchoscopic specimens may expedite the diagnosis of di
111 ernative minimally invasive approaches using bronchoscopic techniques including valves, coils, vapour
112 gned and executed research studies utilizing bronchoscopic techniques will significantly add to our k
113 ng the roles of volumetric imaging, advanced bronchoscopic technologies, and limited surgical resecti
117 Rationale: Bronchial thermoplasty (BT) is a bronchoscopic treatment for severe asthma targeting airw
120 h severe emphysema followed up for 6 months, bronchoscopic treatment with nitinol coils compared with
122 f the more diseased upper lobe segments with bronchoscopic vapour ablation led to clinical improvemen
123 d underwent surgical volume reduction (SVR), bronchoscopic volume reduction (BVR), or bronchoscopy al